Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2015-11-15 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TIGNIEU-JAMEYZIEU (38230), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES DAUPHINS : revenue, balance sheet and financial ratios
PHARMACIE DES DAUPHINS is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TIGNIEU-JAMEYZIEU (38230),
this company of category PME
shows in 2024 a net income positive of 210 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES DAUPHINS (SIREN 817617293)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
210 214 €
267 264 €
253 434 €
275 982 €
161 692 €
163 974 €
171 037 €
163 163 €
52 566 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DES DAUPHINS generates positive net income of 210 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 53 k€ -> 210 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
210 214 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 61%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
60.918%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.849%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES DAUPHINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1791.126
947.051
549.056
362.014
302.718
201.286
138.106
95.015
60.918
Financial autonomy
4.429
7.812
13.362
18.734
21.656
28.447
34.089
44.097
48.849
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
60.922024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-14 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES DAUPHINS (60.92) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.85%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES DAUPHINS (48.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 133.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
133.135
Liquidity indicators evolution PHARMACIE DES DAUPHINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
116.805
126.523
137.837
123.896
189.826
192.371
163.044
186.57
133.135
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
133.132024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-7 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES DAUPHINS (133.13) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DES DAUPHINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES DAUPHINS is estimated at
2 934 742 €
(range 2 043 708€ - 4 390 543€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2043k€2934k€4390k€
2 934 742 €Range: 2 043 708€ - 4 390 543€
NAF 5 année 2024
Valuation method used
Net Income Multiple
210 214 €
×
14.0x
=2 934 743 €
Range: 2 043 709€ - 4 390 543€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES DAUPHINS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES DAUPHINS
What is the revenue of PHARMACIE DES DAUPHINS ?
The revenue of PHARMACIE DES DAUPHINS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES DAUPHINS profitable?
Yes, PHARMACIE DES DAUPHINS generated a net profit of 210 k€ in 2024.
Where is the headquarters of PHARMACIE DES DAUPHINS ?
The headquarters of PHARMACIE DES DAUPHINS is located in TIGNIEU-JAMEYZIEU (38230), in the department Isere.
Where to find the tax return of PHARMACIE DES DAUPHINS ?
The tax return of PHARMACIE DES DAUPHINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES DAUPHINS operate?
PHARMACIE DES DAUPHINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart